[
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow",
    "summary": "2026-01-13. The following slide deck was published by Gilead Sciences, Inc.",
    "url": "https://finnhub.io/api/news?id=5402386b2a3618738ff7d4afd5bd7a3449cbb6ab5acb179ea15dc4dcc2b269e7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768347066,
      "headline": "Gilead Sciences, Inc. (GILD) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow",
      "id": 138090139,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "2026-01-13. The following slide deck was published by Gilead Sciences, Inc.",
      "url": "https://finnhub.io/api/news?id=5402386b2a3618738ff7d4afd5bd7a3449cbb6ab5acb179ea15dc4dcc2b269e7"
    }
  },
  {
    "ts": null,
    "headline": "Ex-Lazard Banker Charged in Insider Trading Case Tied to Health-Care Deals",
    "summary": "US authorities accuse a former Lazard banker of tipping health-care mergers that generated about $41 million in illegal profits.",
    "url": "https://finnhub.io/api/news?id=c273dddbbc9262061c34e9b115ecd1963184b84d715f54b888477c667e15fe92",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768327269,
      "headline": "Ex-Lazard Banker Charged in Insider Trading Case Tied to Health-Care Deals",
      "id": 138086806,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "US authorities accuse a former Lazard banker of tipping health-care mergers that generated about $41 million in illegal profits.",
      "url": "https://finnhub.io/api/news?id=c273dddbbc9262061c34e9b115ecd1963184b84d715f54b888477c667e15fe92"
    }
  },
  {
    "ts": null,
    "headline": "JPM26: HIV pipeline dosing optionality gives Gilead advantage",
    "summary": "Speaking at the J.P. Morgan Healthcare Conference 2026, CEO Daniel O’Day said that the company has seven pipeline drugs for HIV.",
    "url": "https://finnhub.io/api/news?id=bc26bc7ffda4843a6563aa574b78c9ce21be8055cda5b0c76f28b2d7748013d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768308433,
      "headline": "JPM26: HIV pipeline dosing optionality gives Gilead advantage",
      "id": 138083444,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Speaking at the J.P. Morgan Healthcare Conference 2026, CEO Daniel O’Day said that the company has seven pipeline drugs for HIV.",
      "url": "https://finnhub.io/api/news?id=bc26bc7ffda4843a6563aa574b78c9ce21be8055cda5b0c76f28b2d7748013d3"
    }
  }
]